Potential effects of bisphosphonates on bone ultrastructure

Osteoporosis International

Volumn 20, Issue 6, 2009, Pages 1093-1095

  Roux, C ^a  

^a Institut Cochin   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; HYDROXYAPATITE; IBANDRONIC ACID; RISEDRONIC ACID; ZOLEDRONIC ACID;

BINDING AFFINITY; BONE; BONE BIOPSY; BONE DENSITY; BONE MINERALIZATION; BONE STRENGTH; CANCELLOUS BONE; CONFERENCE PAPER; DRUG EFFECT; HUMAN; HYDROGEN BOND; LONG TERM CARE; OSTEOBLAST; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; ULTRASTRUCTURE;

BONE AND BONES; BONE DENSITY; DIPHOSPHONATES; FEMALE; FRACTURES, BONE; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL;

EID: 67349171474     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-009-0865-6     Document Type: Conference Paper

References (11)

1. PM Chavassieux ME Arlot C Reda L Wei JA Yates PJ Meunier 1997 Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis J Clin Invest 100 1475 1480
2. RR Recker RS Weinstein CH Chesnut III RC Schimmer P Mahoney C Hughes 2004 Histomorphometric evaluation of daily and intermittent oral ibandronate in women with post menopausal osteoporosis: results from the BONE study Osteoporos Int 15 231 237
3. RR Recker PD Delmas J Halse IR Reid S Boonen PA Garcia-Hernandez 2008 Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure J Bone Miner Res 23 6 16
4. GY Boivin PM Chavassieux AC Santora JA Yates PJ Meunier 2000 Alendronate increases bone strength by increasing the mean degree of mineralisation of bone tissue in osteoporotic women Bone 27 687 694
5. P Roschger S Rinnerthaler JA Yates GA Rodan P Fratzl K Klaushoffer 2001 Alendronate increases degree and uniformity of mineralisation in cancellous bone and decreases the porosity in cortical bone of osteoporotic women Bone 29 185 191
6. B Borah TE Dufresne EL Ritman SM Jorgensen S Liu PA Chmielewski 2006 Long-term risedronate treatment normalizes mineralisation and continues to preserve trabecular architecture: sequential triple biopsy studies with micro-computed tomography Bone 39 345 352
7. B Borah EL Ritman TE Dufresne SM Jorgensen S Liu J Sacha 2005 The effect of risedronate on bone mineralisation as measured by micro-computed tomography with synchroton radiation: correlation to histomorphometric indices of turnover Bone 37 1 9
8. R Zoehrer P Roschgber EP Paschalis JG Hofstaetter E Durchschlag P Fratzl 2006 Effects of 3- and 5-year treatment with risedronate on bone mineralisation density distribution in triple biopsies of the iliac crest in postmenopausal women J Bone Miner Res 21 1106 1112
9. P Fratzl P Roschger N Fratzl-Zelman EP Paschalis R Phipps K Klaushofer 2007 Evidence that treatment with risedronate in women with post menopausal osteoporosis affects bone mineralisation and bone volume Calcif Tissue Int 81 73 80
10. E Durchschlag EP Paschalis R Zoehrer P Roschger P Fratzl R Recker 2006 Bone material properties in trabecular bone form human iliac crest biopsies after 3- and 5-year treatment with risedronate J Bone Miner Res 21 1581 1590
11. RGG Russell NB Watts FH Ebetino MJ Rogers 2008 Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy Osteoporos Int 19 733 759